A message from the CEO: FY26 was a record year, grounded in science
We closed the year with record revenue, up more than three fold on the prior year, and an…
news
Latest content
Redenlab awarded $2.5M to scale AI-driven speech biomarkers for dementia detection
Receiving the CUREator+ Dementia & Cognitive Decline funding marks a meaningful milestone in our journey to transform how…
Redenlab contributes to position paper on advancing digital healthtechnologies for frontotemporal degeneration
MEDIA RELEASE MELBOURNE, VIC – A major collaborative paper published in Alzheimer’s & Dementia introduces a critical roadmap…
